Oryzon Genomics SA (ORN) Balance Sheet

Oryzon Genomics SA's total assets for Q2 2025 were €138.35M, an increase of 28.91% from the previous quarter. DE:ORN total liabilities were €24.13M for the fiscal quarter, a 9.94% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.